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OPEN

It takes two to tango: NAD+ and sirtuins in aging/longevity
control
Shin-ichiro Imai1 and Leonard Guarente2,3
The coupling of nicotinamide adenine dinucleotide (NAD+) breakdown and protein deacylation is a unique feature of the family of
proteins called ‘sirtuins.’ This intimate connection between NAD+ and sirtuins has an ancient origin and provides a mechanistic
foundation that translates the regulation of energy metabolism into aging and longevity control in diverse organisms. Although the
ﬁeld of sirtuin research went through intensive controversies, an increasing number of recent studies have put those controversies
to rest and fully established the signiﬁcance of sirtuins as an evolutionarily conserved aging/longevity regulator. The tight
connection between NAD+ and sirtuins is regulated at several different levels, adding further complexity to their coordination in
metabolic and aging/longevity control. Interestingly, it has been demonstrated that NAD+ availability decreases over age, reducing
sirtuin activities and affecting the communication between the nucleus and mitochondria at a cellular level and also between the
hypothalamus and adipose tissue at a systemic level. These dynamic cellular and systemic processes likely contribute to the
development of age-associated functional decline and the pathogenesis of diseases of aging. To mitigate these age-associated
problems, supplementation of key NAD+ intermediates is currently drawing signiﬁcant attention. In this review article, we will
summarize these important aspects of the intimate connection between NAD+ and sirtuins in aging/longevity control.
npj Aging and Mechanisms of Disease (2016) 2, 16017; doi:10.1038/npjamd.2016.17; published online 18 August 2016

IT’S SO LONG AGO
Since the ﬁrst discovery of nicotinamide adenine dinucleotide
(NAD+)-dependent deacetylase activity of the silent information
regulator 2 (Sir2) family (‘sirtuins’),1 the ﬁeld of sirtuin biology has
been evolving rapidly over the past 16 years. Many researchers
from different ﬁelds have encountered sirtuins in their own
research, enriching our knowledge of this fascinating family of
enzymes. It is now clear that sirtuins are involved in the regulation
of many fundamental biological processes throughout the body.2,3
Furthermore, it has been revealed that sirtuins possess much
broader enzymatic activities, namely, deacylases, including
deacetylase, desuccinylase, demaloynylase, deglutarylase,
long-chain deacylase, lipoamidase, and ADP-ribosyltransferase.4,5
All these enzymatic activities speciﬁcally require NAD+, and the
catalytic mechanism of this NAD+ dependency has been studied
extensively.6 Clearly, sirtuins have evolved to respond to the
availability of NAD+, an essential currency of cellular metabolism
and DNA damage repair, and convert this information to
many different biological outputs. In this particular review article,
we will focus on this intimate connection between sirtuin function,
aging/longevity control in particular, and their indispensable
co-substrate, NAD+.
The origin of the connection between NAD+ and sirtuins is
ancient. For instance, vibriophage KVP40 possesses a minimal set of
genes for NAD+ biosynthesis and consumption, namely, the genes
encoding two key NAD+ biosynthetic enzymes, nicotinamide
phosphoribosyltransferase (NAMPT) and nicotinamide/nicotinic
acid mononucleotide adenylyltransferase (NMNAT),2,3 and a sirtuin
family protein (Figure 1).7 Although why such a minimalistic

organism keeps these three genes in its genome remains unclear,
one potential explanation is that controlling the host cell’s
metabolism and proliferation in a NAD+-dependent manner could
provide beneﬁts for this particular vibriophage to efﬁciently
produce progeny in the host cell. Such a NAD+/sirtuin-mediated
virus–host relationship might be a prototype for the much more
complex inter-tissue communication mediated by NAMPT and the
mammalian sirtuin SIRT1.8 As discussed later in this review, NAMPT
and SIRT1 comprise multiple layers of feedback regulatory loops
inside cells and between tissues and organs, and contribute to the
systemic regulation of mammalian aging and longevity.9–12
Another interesting example is the connection between the
nicotinamidase Pnc1 and Sir2 proteins in yeast, worms, and ﬂies.
Whereas vertebrates and a limited number of bacterial species
mainly use NAMPT to synthesize NAD+ from nicotinamide,
invertebrates and most bacterial species use nicotinamidase to
convert nicotinamide to nicotinic acid and synthesize NAD+ from
nicotinic acid (Figure 1).13 Pnc1 regulates NAD+ biosynthesis and
affects lifespan in those organisms.14–16
Although all genetic, pathophysiological, and pharmacological
studies point out that sirtuin activity can be affected by changes in
NAD+ levels, whether sirtuin activity is indeed regulated by the
physiological ﬂuctuation of NAD+ has been of great debate.
However, a recent detailed kinetic study has demonstrated that at
least for deacetylase activities of SIRT1-3, each Km for NAD+ is
consistent with the notion that changes in NAD+ levels in each
subcellular compartment can directly regulate sirtuin activity.17
These ﬁndings further afﬁrm the functional connection between
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Figure 1. Comparison of NAD+ biosynthetic pathways between yeast/invertebrates and mammals. Left panel: NAD+ biosynthetic pathways in
the budding yeast Saccharomyces cerevisiae and invertebrates. The pathways from NIC, NA, and NR and the de novo pathway from tryptophan
are shown. Right panel: NAD+ biosynthetic pathways in mammals. In mammals, NIC is a predominant NAD+ precursor. NA, NR, and tryptophan
can also be utilized to synthesize NAD+. The de novo pathway and the NAD+ biosynthetic pathway from NA are evolutionarily conserved,
whereas the NAD+ biosynthetic pathway from NIC is mediated by NAMPT. In this ﬁgure, only sirtuins are shown among multiple
NAD+-consuming enzymes that break NAD+ into nicotinamide and ADP-ribose. Mammals have two NR kinases (Nrk1 and 2) and
ecto-5′-nucleotidase CD73 to produce NMN and NR, respectively. NA, nicotinic acid; NAD+, nicotinamide adenine dinucleotide; NAMPT,
nicotinamide phosphoribosyltransferase; NIC, nicotinamide; NR, nicotinamide riboside; Nrk1, nicotinamide ribose kinase 1; Npt1, nicotinic acid
phosphoribosyltransferase; Nma1, 2, nicotinic acid mononucleotide adenylyltransferase 1, 2; Nnt1, nicotinamide-N-methyltransferase; Npt,
nicotinic acid phosphoribosyltransferase; NMNAT, NMN adenylyltransferase; NNMT, nicotinamide-N-methyltransferase; NaMN, nicotinic acid
mononucleotide; NMN, nicotinamide mononucleotide; Pho5, 8, phosphatase 5, 8; Pnp1, purine nucleoside phosphorylase; Pnc1,
nicotinamidase; Qpt, quinolinic acid phosphoribosyltransferase; Qns1, NAD synthetase; Qpt1, quinolinic acid phosphoribosyltransfease;
Urh1, uridine hydrolase.

NAD+ and sirtuins. We will now look into several important cases
of this connection in diverse organisms.
LEARNED ALL THE GAMES
The history of sirtuin research in the past 16 years has been a
steep winding road. In this history, the biggest controversy was
whether sirtuins are truly an evolutionarily conserved regulator for
aging and longevity in diverse organisms. Although early studies
demonstrated that Sir2 and its orthologs have a critical role in
aging/longevity control in yeast, worms, and ﬂies,18–20 subsequent
studies reported contradictory results,21,22 bringing considerable
debates on the role of sirtuins in aging/longevity control.
However, this controversy has ﬁnally been put to the end
because an increasing number of recent studies have successfully
reconﬁrmed the original claims.23–30 Even in mammals, the
brain-speciﬁc SIRT1-overexpressing (BRASTO) transgenic mice
have been demonstrated to exhibit signiﬁcant delay in aging
and lifespan extension in both male and female mice.27 Given that
the whole-body SIRT1-overexpressing transgenic mice fail to show
lifespan extension,22 this study strongly suggests that SIRT1 in the
brain, more speciﬁcally in the hypothalamus, is a key to control
aging and longevity in mammals.31 In addition, whole-body SIRT6
transgenic mice have been reported to show lifespan extension,
although only males exhibit the phenotype.24 These recent studies
have established a ﬁrm foundation for the signiﬁcance of sirtuins
as an evolutionarily conserved aging/longevity regulator.32–34
Interestingly, the connection between NAD+ and sirtuins has
also been demonstrated to be crucial in aging/longevity control
(Figure 2). In yeast, caloric restriction (CR), achieved by lowering
glucose in the media from regular 2% down to 0.5% or 0.05%,
npj Aging and Mechanisms of Disease (2016) 16017

substantially extends lifespan, and the lifespan extension by
moderate CR (0.5% glucose) is dependent on Sir2 or nicotinic acid
phosphoribosyltransferase Npt1.35 A more severe regimen of CR
(0.05% glucose) extends lifespan by a different mechanism that is
independent of Sir2 but dependent of the nutrient-responsive
kinases, PKA, TOR, and the Akt ortholog Sch9.36 In addition,
induction of nicotinamidase Pnc1, which is upstream of Npt1, is
necessary and sufﬁcient for lifespan extension by CR (Figure 2a).14
Nicotinamide riboside (NR), a key NAD+ intermediate, is produced
and secreted by yeast cells,37,38 and exogenous NR increases
NAD+ biosynthesis and promotes lifespan through two
independent pathways, the one mediated by NR kinase Nrk1
and the other mediated by uridine hydrolase Urh1 and purine
nucleoside phosphorylase Pnp1.39 In worms, lifespan extension
mediated by CR requires Sir-2.1 and Pnc1.40 In addition, NR is also
able to promote lifespan in a Sir-2.1-dependent manner.25
Overexpression of the Drosophila nicotinamidase, D-NAAM, also
extends lifespan in ﬂies, and this lifespan extension is
Sir2-dependent.15 These ﬁndings strongly suggest the importance
of the connection between NAD+ and sirtuins in aging/longevity
control in these organisms, which utilize nicotinic acid and
nicotinamide ribose as main sources for NAD+ biosynthesis.
Different from yeast, worms, and ﬂies, mammals do not have
Pnc1 homologs but utilize NAMPT instead, converting
nicotinamide, an amide form of vitamin B3, and 5′-phosphoribosyl-pyrophosphate to nicotinamide mononucleotide (NMN),
another key NAD+ intermediate (Figure 1).41,42 NMN is adenylated
to NAD+ by three NMN adenylyltransferases, NMNAT1-3. It has
been well established that the NAMPT-mediated NAD+
biosynthetic pathway regulates sirtuin activity in the nucleus and
mitochondria.43–47 Just like Pnc1 in lower eukaryotes, NAMPT is
Published in partnership with the Japanese Society of Anti-Aging Medicine
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Figure 2. Responses of NAD+ biosynthetic enzymes and sirtuins to
nutritional and environmental cues in aging/longevity control.
(a) Responses of PNC1 and sirtuins in budding yeast Saccharomyces
cerevisiae and invertebrates (worms and ﬂies) to caloric restriction
(CR) and stress. When PNC1 levels increase in response to CR or
stress in these organisms, the NAD+ biosynthetic ﬂux increases
and nicotinamide levels decrease, both contributing to the
enhancement of sirtuin activity. (b) Responses of NAMPT and
sirtuins in mammals to CR, exercise, and stress. Upregulation of
NAMPT activates sirtuins primarily through the increase in NAD+
biosynthesis because nicotinamide levels are normally much lower
in mammals, compared to yeast. CR, caloric restriction; NAD+,
nicotinamide adenine dinucleotide; NAMPT, nicotinamide
phosphoribosyltransferase.

also induced in rodents and humans by low glucose, fasting, CR,
exercise, and a variety of stress and damage (Figure 2b).47–51
An unique feature of this particular NAD+ biosynthetic pathway is
that transcription of the Nampt gene is mediated by the key
circadian transcription factors CLOCK/BMAL, rendering NAD+
biosynthesis and the activity of sirtuins circadian. In addition,
SIRT1 and SIRT6 feedback on the circadian oscillator in peripheral
tissues and likely in the suprachiasmatic nucleus of the
hypothalamus.43,45,52 The circadian oscillation of NAD+ drives at
least SIRT1, SIRT3, and SIRT6 activities, impacting a variety of
metabolic functions, including glucose, cholesterol, and fatty acid
metabolism (Figure 3).44,53
Most recently, another interesting connection between
NAMPT/NAD+ and SIRT1 has been found.8 Mammals have two
different forms of NAMPT, intra- and extracellular NAMPT (iNAMPT
and eNAMPT, respectively). iNAMPT is acetylated in white and
brown adipose tissue. When iNAMPT is speciﬁcally deacetylated at
lysine 53 by SIRT1, the protein is predisposed to secretion, and its
enzymatic activity is enhanced. Surprisingly, eNAMPT secreted by
adipose tissue remotely controls NAD+ biosynthesis, SIRT1
activity, and neural activity in the hypothalamus, which affects
physical activity of mice during the dark phase and in response to
fasting. These ﬁndings imply that adipose tissue communicates
with other tissues through the secretion of eNAMPT, and regulates
the spatial and temporal coordination of NAD+ biosynthesis at a
systemic level. Given that the hypothalamus functions as a
high-order ‘control center of aging’ in mammals,27,54 it is
conceivable that adipose tissue functions as a ‘modulator’ of this
control center (see Figure 5). Indeed, knock-in mice in which
iNAMPT is overexpressed speciﬁcally in adipose tissue (ANKI mice)
show signiﬁcant increases in circulating eNAMPT levels, hypothalamic NAD+ and SIRT1 target gene expression, and physical
activity, particularly in response to fasting.8 Therefore, it will be of
great interest to examine whether these ANKI mice show a
signiﬁcant slowing in aging and lifespan extension.
Published in partnership with the Japanese Society of Anti-Aging Medicine

Figure 3. Circadian regulation of NAD+ biosynthesis and metabolism
by NAMPT and sirtuins. Nampt is one of the SIRT1/CLOCK/BMAL1regulated circadian genes, and SIRT1 and NAMPT comprise a novel
circadian regulatory feedback loop, producing the circadian
oscillation of NAD+. This circadian oscillation of NAD+ drives SIRT1,
SIRT3, and SIRT6 activities. SIRT1 feedbacks the key circadian
transcription factors CLOCK/BMAL and regulates genes related to
peptide and cofactor biosynthesis in the liver. SIRT1 also regulates
Bmal1 expression through PGC-1α in the suprachiasmatic nucleus.
SIRT6 controls the chromatin recruitment of CLOCK/BMAL1 and
SREBP1 and regulates genes related to lipid and carbohydrate
metabolism. SIRT3 regulates oxidative metabolism in mitochondria
through circadian deacetylation of mitochondrial oxidative
enzymes. All these circadian activity changes of sirtuins produce
robust metabolic outputs in many different tissues and organs.
NAD+, nicotinamide adenine dinucleotide; NAMPT, nicotinamide
phosphoribosyltransferase.

Given that NAMPT and NAD+ levels display robust circadian
oscillation in peripheral tissues,45 it is conceivable that eNAMPT
secretion would also show circadian oscillation. Indeed, it has
been reported that serum eNAMPT levels follow a diurnal rhythm,
making a peak during early afternoon, in humans,55 which
appears to be opposite to plasma eNAMPT oscillation in mice
(a preliminary observation in the Imai lab). This eNAMPT oscillation
would likely produce another oscillation of its enzymatic reaction
product, NMN, in blood circulation. NMN is rapidly incorporated to
major metabolic tissues and converted to NAD+.56 Therefore, in
mammals, adipose tissue has an important role in generating the
circadian oscillation of eNAMPT and possibly NMN in blood
circulation, potentially synchronizing metabolic and neurobehavioral functions through other peripheral tissues and the
hypothalamus in a circadian rhythm-dependent manner. In each
tissue, NAD+ and sirtuins are critical mediators to orchestrate such
inter-tissue communications. The loss of this orchestration is likely
an important driver of aging in a wide variety of organisms.
ALL THE THINGS THAT WERE SAID
The functional connection between NAD+ and sirtuins is regulated
at at least three levels: (1) regulation of NAD+ biosynthesis, (2)
modulation of sirtuin activity by NAD+ substrates and derivatives,
and (3) competitive utilization of NAD+ between sirtuins and other
NAD+ consumers (Figure 4).
First, the pathophysiological changes in NAD+ biosynthesis
affect sirtuin activity. For instance, in mammals, NAMPT and NAD+
levels decline with age in multiple organs, such as
pancreas, adipose tissue, skeletal muscle, liver, and brain.25,56–58
Inﬂammatory, ischemic, and degenerative disease conditions also
decrease NAMPT-mediated NAD+ biosynthesis.56,59–62 Although
precise molecular mechanisms for the decline in NAMPT-mediated
npj Aging and Mechanisms of Disease (2016) 16017
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Figure 4. Regulation of the functional connection between NAD+
and sirtuins. There are at least three levels of regulation: (1)
regulation of NAD+ biosynthesis, particularly mediated by NAMPT,
(2) modulation of sirtuin activity, including inhibition by nicotinamide and NADH and activation of SIRT6 by long-chain fatty acids,
and (3) competition with other NAD+-consuming enzymes, such as
PARPs and CD38/157 ectoenzymes. See details in text. NAD+,
nicotinamide adenine dinucleotide; NAMPT, nicotinamide phosphoribosyltransferase; PARPs, poly-ADP-ribose polymerases.

NAD+ biosynthesis remain unclear, it has been suggested that
oxidative stress and/or inﬂammatory cytokines decrease NAMPT
expression.56 Such pathophysiological decline in NAD+
biosynthesis decreases sirtuin activity, likely contributing to the
development of age-associated pathophysiologies. For this
reason, boosting NAD+ biosynthesis by using key NAD+
intermediates, such as NMN and NR, is now drawing signiﬁcant
attention as an efﬁcient therapeutic intervention against diseases
of aging, such as type 2 diabetes, Alzheimer’s disease, heart
failure, and hearing loss.2,3 Thus, the regulation of NAD+
biosynthesis is one of the most important factors that affect the
functional connection between NAD+ and sirtuins.
Second, sirtuin activity can also be modulated by NAD+
substrates and derivatives, such as nicotinamide and NADH, and
other molecules. Nicotinamide, which is released from NAD+
during the deacylation reaction of sirtuins, functions as a
non-competitive inhibitor.63 The ability of nicotinamide to inhibit
deacylation by sirtuins is dependent on the type of acyl
substrates.17 For instance, for SIRT1, the IC50 for nicotinamide is
175 μM for the acetylated substrate but signiﬁcantly less for
longer chain acyl substrates. On the other hand, SIRT3 shows an
opposite trend for nicotinamide inhibition. Whereas the calculated
concentration of endogenous nicotinamide ranges from 10 to
150 μM in yeast,63 plasma nicotinamide concentrations range
from 0.3 (human) to 5 μM (mouse) in mammals.64–66 Therefore,
nicotinamide might be more critical for the regulation of sirtuin
activity in lower eukaryotes that tend to have higher endogenous
nicotinamide concentrations. The NAD+/NADH ratio has also been
proposed to be a critical parameter for the regulation of sirtuin
activity due to the capability of NADH as a competitive inhibitor.67
However, the subsequent studies have shown that the IC50 for
NADH surpasses reported physiological ranges of NADH so that it
is unlikely that NADH could function as a physiologically relevant
competitive inhibitor for sirtuins, at least in mammals.44,68,69 Most
recently, it has been demonstrated that the enzymatic activities of
some sirtuins, particularly SIRT6, are regulated by long-chain fatty
acids.70 Several free fatty acids, including myristic, oleic, and
linoleic acids, at physiological concentrations are able to enhance
SIRT6 deacetylase activity at K9 and K56 of histone H3 up to
35-fold. Taken together, these studies suggest that the connection
between NAD+ and sirtuins can be modiﬁed by physiologically
relevant endogenous NAD+ derivatives and other compounds.
npj Aging and Mechanisms of Disease (2016) 16017

Figure 5. Importance of the communication between the nucleus
and mitochondria at a cellular level (a) and between the
hypothalamus and adipose tissue at a systemic level (b) in aging/
longevity control. See details in text.

Lastly, the availability of NAD+ is under a ﬁerce competition
among NAD+-consuming enzymes, including sirtuins, polyADP-ribose polymerases (PARPs), and CD38/157 ectoenzymes.2,3
Particularly, SIRT1 and PARP1 compete with each other, and
genetic ablation and pharmacological inhibition of PARP1 increase
NAD+ content and SIRT1 activity and enhance oxidative
metabolism.71 Similar ﬁndings were also reported in CD38
knockout mice.72,73 Interestingly, it has been shown that PARP is
chronically activated in aging worms and mice, resulting in an
increase in poly-ADP-ribosylation of cellular proteins.25
This chronic PARP activation, which might potentially be caused
by an increase in chronic nuclear DNA damage, could lead
to NAD+ depletion and decrease sirtuin activity, likely contributing
to age-associated pathophysiologies.
IT TAKES TWO TO TANGO
How does this intimate interplay between NAD+ and sirtuins
contribute to aging/longevity control? At a cellular level, the
communication between the nucleus and mitochondria seems to
be compromised when NAD+ availability declines and thereby
sirtuin activity decreases over age (Figure 5a). Interestingly, NAD+
deﬁciency causes a pseudohypoxic state through decreased SIRT1
activity.57 The defect in SIRT1 activity stabilizes HIF-1α, leading to
an abnormal high level of HIF-1α. Because HIF-1α sequesters
c-Myc, the gene encoding the mitochondrial transcription factor
TFAM can no longer be activated by c-Myc (Figure 5a). In aged
skeletal muscle, this defective TFAM expression causes signiﬁcant
reduction in mitochondrial gene expression, leading to mitochondrial metabolic dysfunction. Decreased SIRT1 activity also reduces
the functions of PGC-1α and FOXO1, resulting in the reduction in
mitochondrial biogenesis, oxidative metabolism, and anti-oxidant
defense pathways.74,75 Furthermore, it has recently been
demonstrated that SIRT1 and SIRT3 activities are involved in the
mitochondrial unfolded protein response (UPRmt) pathway and
mitophagy (Figure 5a).25,76 For instance, mammalian SIRT1,
C. elegans sir-2.1, and NAD+ enhancement by NR all activate
UPRmt genes, such as hsp-6 (C. elegans) and HSP60 (mammals), in
worms, mammalian cells, and skeletal muscle stem cells.25,77
Interestingly, the activation of UPRmt is tightly associated with
mitonuclear protein imbalance, as deﬁned by the decreased ratio
between the nuclear DNA-encoded ATP5A and the mitochondrial
Published in partnership with the Japanese Society of Anti-Aging Medicine
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DNA-encoded MTCO1 (cytochrome c oxidase subunit 1), and both
UPRmt and mitonuclear protein imbalance are proposed to have
a critical role in aging and longevity control.78 SIRT3 appears to be
a part of UPRmt, and mitochondrial proteotoxic stress increases
SIRT3 protein levels, inducing mitophagy and anti-oxidant
response.76 Therefore, the breakdown of the intimate interplay
between NAD+ and sirtuins causes serious mitochondrial
dysfunction, a hallmark of aging, through these nuclearmitochondrial communication mechanisms.
At a systemic level, the communication between the control
center of aging (the hypothalamus) and its modulator (adipose
tissue) might be compromised when systemic NAD+ biosynthesis
decreases (Figure 5b). As discussed in the previous section,
adipose tissue remotely controls the hypothalamus through the
secretion of eNAMPT. On the other hand, the hypothalamus also
appears to control adiposity through a SIRT1-dependent signaling
pathway. In the dorsomedial hypothalamus (DMH), SIRT1 and its
binding partner Nkx2-1 have an important role in regulating aging
and longevity.27 PR domain containing 13 (Prdm13) has recently
been identiﬁed as one of the DMH-speciﬁc downstream target
genes in the SIRT1/Nkx2-1 signaling pathway.79 Interestingly,
DHM-speciﬁc Prdm13-knockdown mice exhibit decreased sleep
quality and increased adiposity with no change in food intake, an
interesting mimicry of age-associated pathophysiology. When
NAD+ availability declines with age, it is likely that the secretion of
enzymatically active eNAMPT would be affected in adipose tissue
so that the hypothalamus would not be able to synthesize
adequate levels of NAD+ from circulating NMN for its function
(Figure 5b). This would lead to a decrease in Prdm13 expression in
the DMH, as observed indeed in aged hypothalamus,79 and an
increase in adiposity. An interesting question is whether
circulating eNAMPT levels would also increase as a compensatory
response to sustain hypothalamic NAD+ levels. Although the study
that tries to answer this question is currently underway, the
systemic feedback loop between the hypothalamus and adipose
tissue, mediated by the connection between NAD+ and SIRT1 in
each tissue, is critical, contributing to the maintenance of
physiological robustness. Therefore, the breakdown of this
intimate interplay between NAD+ and sirtuins, particularly SIRT1,
in each tissue likely leads to the breakdown of the inter-tissue
communication between the hypothalamus and adipose tissue,
resulting in systemic functional decline over age and eventually
limiting lifespan in mammals.

CONCLUDING REMARKS
The tight functional connection between NAD+ and sirtuins has a
critical role in regulating physiological robustness, and
contributing to aging/longevity control in diverse organisms.
Recent studies have demonstrated that NAD+ availability declines
over age due to the defect in NAMPT-mediated NAD+ biosynthesis
and the PARP-mediated NAD+ depletion, reducing sirtuin activities
and affecting the communication between the nucleus and
mitochondria at a cellular level and also the inter-tissue
communication, particularly between the hypothalamus and
adipose tissue, at a systemic level. These events likely cause
age-associated pathophysiologies and contribute to the
pathogenesis of diseases of aging. For this reason, supplementing
key NAD+ intermediates, such as NMN and NR, is expected to
mitigate age-associated functional decline and ameliorate a
variety of age-associated pathophysiologies. The connection
between NAD+ and sirtuins will provide deep mechanistic insight
into how energy metabolism shapes the process of aging and
determines lifespan in evolutionarily diverse organisms.
Published in partnership with the Japanese Society of Anti-Aging Medicine
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